Last 12 months
Inside the activity.
3 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 3 |
| Dec 2025 | 2 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 15, 2026 22:25 UTC |
Russotti GregorySee Remarks
|
SaleCommon Stock | 2,587 | $1.93 | $4,992.91 |
DisclosureSEC source: 0001867305-26-000014 · form4-09152026_100952.xml · nonDerivative · entry 1 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 509,198 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 22:25 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 1,658 | $1.93 | $3,199.94 |
DisclosureSEC source: 0001867173-26-000020 · form4-09152026_100903.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 502,907 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 22:23 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
Tax withholdingCommon Stock | 13,850 | $1.94 | $26,869.00 |
DisclosureSEC source: 0002001162-26-000018 · form4-09152026_100955.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,633,839 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 09, 2026 Filed Sep 10, 2026 21:48 UTC |
Truitt JosephDirector
|
GrantStock Option (right to buy) · Derivative | 148,000 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001452429-26-000005 · form4-09102026_090949.xml · derivative · entry 1 Truitt Joseph · CIK 0001452429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,000 Underlying: Common Stock · 148,000 shares Expires 2036-09-09 F1 · derivative.exercise_date: Century Therapeutics, Inc. (the "Company") issued to the Reporting Person stock options (the "Options") in connection with his appointment as a director. The Options vest in equal monthly installments over 36 months subject to the Reporting Person's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 20:35 UTC |
Russotti GregorySee Remarks
|
SaleCommon Stock | 534 | $2.05 | $1,094.70 |
DisclosureSEC source: 0001867305-26-000012 · form4-09092026_080938.xml · nonDerivative · entry 1 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 511,785 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 20:34 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 254 | $2.05 | $520.70 |
DisclosureSEC source: 0001867173-26-000018 · form4-09092026_080900.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 504,565 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 20:36 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
Tax withholdingCommon Stock | 463 | $2.11 | $976.93 |
DisclosureSEC source: 0002001162-26-000016 · form4-09092026_080950.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,633,839 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:17 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
Tax withholdingCommon Stock | 31,172 | $1.92 | $59,850.24 |
DisclosureSEC source: 0002001162-26-000014 · form4-08182026_080855.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,634,302 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:08 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 275 | $1.98 | $543.68 |
DisclosureSEC source: 0001867173-26-000016 · form4-08052026_080803.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 504,819 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 23:56 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 1,654 | $2.23 | $3,691.73 |
DisclosureSEC source: 0001867173-26-000014 · form4-06152026_110627.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 505,094 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 23:57 UTC |
Russotti GregorySee Remarks
|
SaleCommon Stock | 2,584 | $2.23 | $5,767.49 |
DisclosureSEC source: 0001867305-26-000010 · form4-06152026_110632.xml · nonDerivative · entry 1 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 512,319 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:08 UTC |
Riva AlessandroDirector
|
GrantStock Option (right to buy) · Derivative | 74,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001867172-26-000006 · form4-06122026_090629.xml · derivative · entry 1 Riva Alessandro · CIK 0001867172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,000 Underlying: Common Stock · 74,000 shares Expires 2036-06-11 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:07 UTC |
Quimi DaphneDirector
|
GrantStock Option (right to buy) · Derivative | 74,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001543031-26-000002 · form4-06122026_090652.xml · derivative · entry 1 Quimi Daphne · CIK 0001543031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,000 Underlying: Common Stock · 74,000 shares Expires 2036-06-11 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:05 UTC |
Lee Han MyungDirector
|
GrantStock Option (right to buy) · Derivative | 74,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0002100154-26-000002 · form4-06122026_090649.xml · derivative · entry 1 Lee Han Myung · CIK 0002100154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,000 Underlying: Common Stock · 74,000 shares Expires 2036-06-11 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:06 UTC |
Murphy Martin PatrickDirector
|
GrantStock Option (right to buy) · Derivative | 74,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0002127581-26-000006 · form4-06122026_090645.xml · derivative · entry 1 Murphy Martin Patrick · CIK 0002127581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,000 Underlying: Common Stock · 74,000 shares Expires 2036-06-11 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:05 UTC |
Blackwell KimberlyDirector
|
GrantStock Option (right to buy) · Derivative | 74,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001816465-26-000002 · form4-06122026_090611.xml · derivative · entry 1 Blackwell Kimberly · CIK 0001816465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,000 Underlying: Common Stock · 74,000 shares Expires 2036-06-11 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 23:54 UTC |
Cowan ChadChief Scientific Officer
|
Tax withholdingCommon Stock | 358 | $2.24 | $801.92 |
DisclosureSEC source: 0002039294-26-000010 · form4-06152026_110619.xml · nonDerivative · entry 1 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,175,322 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 23:55 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
Tax withholdingCommon Stock | 13,849 | $2.24 | $31,021.76 |
DisclosureSEC source: 0002001162-26-000012 · form4-06152026_110631.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,665,474 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 08, 2026 Filed Jun 9, 2026 20:10 UTC |
Russotti GregorySee Remarks
|
SaleCommon Stock | 524 | $2.11 | $1,106.16 |
DisclosureSEC source: 0001867305-26-000008 · form4-06092026_040607.xml · nonDerivative · entry 1 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,903 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 08, 2026 Filed Jun 9, 2026 20:10 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 249 | $2.11 | $525.64 |
DisclosureSEC source: 0001867173-26-000012 · form4-06092026_040605.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 506,748 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 20:10 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
Tax withholdingCommon Stock | 463 | $2.13 | $986.19 |
DisclosureSEC source: 0002001162-26-000010 · form4-06092026_040603.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,679,323 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:10 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
Tax withholdingCommon Stock | 31,172 | $2.34 | $72,942.48 |
DisclosureSEC source: 0002001162-26-000008 · form4-05192026_040501.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,679,786 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 04, 2026 Filed May 6, 2026 21:27 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 264 | $2.34 | $618.02 |
DisclosureSEC source: 0001867173-26-000010 · form4-05062026_090521.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 506,997 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 23:18 UTC |
Cowan ChadChief Scientific Officer
|
Tax withholdingCommon Stock | 1,365 | $2.19 | $2,989.35 |
DisclosureSEC source: 0002039294-26-000008 · form4-04032026_110429.xml · nonDerivative · entry 1 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,175,680 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 20:04 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 7,043 | $2.55 | $17,952.61 |
DisclosureSEC source: 0001867173-26-000008 · form4-03162026_080351.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 507,261 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 20:03 UTC |
Russotti GregorySee Remarks
|
SaleCommon Stock | 10,076 | $2.55 | $25,683.72 |
DisclosureSEC source: 0001867305-26-000006 · form4-03162026_080350.xml · nonDerivative · entry 1 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 515,427 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:05 UTC |
Cowan ChadChief Scientific Officer
|
Tax withholdingCommon Stock | 1,431 | $2.73 | $3,906.63 |
DisclosureSEC source: 0002039294-26-000006 · form4-03132026_080344.xml · nonDerivative · entry 1 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,177,045 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:07 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
Tax withholdingCommon Stock | 55,397 | $2.73 | $151,233.81 |
DisclosureSEC source: 0002001162-26-000006 · form4-03132026_080321.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,710,958 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:11 UTC |
Russotti GregorySee Remarks
|
SaleCommon Stock | 479 | $2.54 | $1,214.74 |
DisclosureSEC source: 0001867305-26-000004 · form4-03112026_080313.xml · nonDerivative · entry 1 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525,503 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:10 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 247 | $2.54 | $626.39 |
DisclosureSEC source: 0001867173-26-000006 · form4-03112026_080344.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,304 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 23:53 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
Tax withholdingCommon Stock | 463 | $2.56 | $1,185.28 |
DisclosureSEC source: 0002001162-26-000004 · form4-03102026_110303.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,766,355 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:12 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
Tax withholdingCommon Stock | 31,172 | $1.75 | $54,551.00 |
DisclosureSEC source: 0001104659-26-017132 · tm266779-1_4seq1.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,766,818 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 21:14 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 323 | $1.82 | $588.51 |
DisclosureSEC source: 0001867173-26-000004 · form4-02052026_090230.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,551 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:15 UTC |
Cowan ChadChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 265,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0002039294-26-000004 · form4-02042026_090252.xml · derivative · entry 3 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,000 Underlying: Common Stock · 265,000 shares Expires 2036-02-02 F3 · derivative.exercise_date: The option vests 25% on February 2, 2027, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:15 UTC |
Cowan ChadChief Scientific Officer
|
GrantCommon Stock | 135,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002039294-26-000004 · form4-02042026_090252.xml · nonDerivative · entry 1 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,178,476 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on February 2, 2027, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:22 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 945,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0002001162-26-000002 · form4-02042026_090254.xml · derivative · entry 2 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 945,000 Underlying: Common Stock · 945,000 shares Expires 2036-02-02 F2 · derivative.exercise_date: The option vests 25% on February 2, 2027, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:22 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
GrantCommon Stock | 475,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002001162-26-000002 · form4-02042026_090254.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,797,990 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on February 2, 2027, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:19 UTC |
Russotti GregorySee Remarks
|
GrantStock Option (right to buy) · Derivative | 265,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001867305-26-000002 · form4-02042026_090235.xml · derivative · entry 3 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,000 Underlying: Common Stock · 265,000 shares Expires 2036-02-02 F2 · derivative.exercise_date: The option vests 25% on February 2, 2027, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:19 UTC |
Russotti GregorySee Remarks
|
GrantCommon Stock | 135,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001867305-26-000002 · form4-02042026_090235.xml · nonDerivative · entry 1 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525,982 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on February 2, 2027, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:12 UTC |
Carr DouglasSVP Finance & Operations
|
GrantStock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001867173-26-000002 · form4-02042026_090202.xml · derivative · entry 2 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2036-02-02 F2 · derivative.exercise_date: The option vests 25% on February 2, 2027, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:12 UTC |
Carr DouglasSVP Finance & Operations
|
GrantCommon Stock | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001867173-26-000002 · form4-02042026_090202.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,874 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on February 2, 2027, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:10 UTC |
Cowan ChadChief Scientific Officer
|
Tax withholdingCommon Stock | 1,611 | $1.00 | $1,602.95 |
DisclosureSEC source: 0002039294-26-000002 · form4-01062026_090146.xml · nonDerivative · entry 1 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,043,476 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:52 UTC |
Cowan ChadChief Scientific Officer
|
PurchaseCommon Stock | 58,060 | $0.85 | $49,252.30 |
DisclosureSEC source: 0002039294-25-000008 · form4-12292025_091223.xml · nonDerivative · entry 1 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,045,087 F1 · kind: All profits from the reported transactions will be disgorged to the issuer pursuant to applicable requirements. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 23:38 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
PurchaseCommon Stock | 52,000 | $0.58 | $30,352.40 |
DisclosureSEC source: 0002001162-25-000009 · form4-12162025_111214.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,322,990 F1 · kind: All profits from the reported transactions will be disgorged to the issuer pursuant to applicable requirements. F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.577 to $0.5838. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:16 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
Tax withholdingCommon Stock | 463 | $0.53 | $243.54 |
DisclosureSEC source: 0002001162-25-000007 · form4-12122025_091213.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,270,990 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 23:04 UTC |
Lee Han MyungDirector
|
GrantStock Option (right to buy) · Derivative | 88,000 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0002100154-25-000004 · form4-12112025_111254.xml · derivative · entry 1 Lee Han Myung · CIK 0002100154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,000 Underlying: Common Stock · 88,000 shares Expires 2035-12-09 F1 · derivative.exercise_date: Century Therapeutics, Inc. (the "Company") issued to the Reporting Person stock options (the "Options") in connection with his appointment as a director. The Options vest in equal monthly installments over 36 months subject to the Reporting Person's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan. Read SEC document |
| December 09, 2025 Filed Apr 10, 2026 21:07 UTC |
Murphy Martin PatrickDirector
|
GrantStock Option (right to buy) · Derivative | 88,000 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0002127581-26-000004 · form4-04102026_090449.xml · derivative · entry 1 Murphy Martin Patrick · CIK 0002127581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,000 Underlying: Common Stock · 88,000 shares Expires 2035-12-09 F1 · derivative.exercise_date: Century Therapeutics, Inc. (the "Company") issued to the Reporting Person stock options (the "Options") in connection with his appointment as a director. The Options vest in equal monthly installments over 36 months subject to the Reporting Person's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:34 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 257 | $0.53 | $136.72 |
DisclosureSEC source: 0001867173-25-000005 · form4-12102025_091245.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,874 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:34 UTC |
Russotti GregorySee Remarks
|
SaleCommon Stock | 526 | $0.53 | $279.83 |
DisclosureSEC source: 0001867305-25-000003 · form4-12102025_091259.xml · nonDerivative · entry 1 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,982 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:05 UTC |
Cowan ChadChief Scientific Officer
|
SaleCommon Stock | 5,462 | $0.50 | $2,736.46 |
DisclosureSEC source: 0002039294-25-000006 · form4-11242025_091151.xml · nonDerivative · entry 1 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 987,027 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.